330 related articles for article (PubMed ID: 12076537)
1. P450 BM3: the very model of a modern flavocytochrome.
Munro AW; Leys DG; McLean KJ; Marshall KR; Ost TW; Daff S; Miles CS; Chapman SK; Lysek DA; Moser CC; Page CC; Dutton PL
Trends Biochem Sci; 2002 May; 27(5):250-7. PubMed ID: 12076537
[TBL] [Abstract][Full Text] [Related]
2. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
[TBL] [Abstract][Full Text] [Related]
3. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
4. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.
Warman AJ; Roitel O; Neeli R; Girvan HM; Seward HE; Murray SA; McLean KJ; Joyce MG; Toogood H; Holt RA; Leys D; Scrutton NS; Munro AW
Biochem Soc Trans; 2005 Aug; 33(Pt 4):747-53. PubMed ID: 16042591
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
[TBL] [Abstract][Full Text] [Related]
6. Flavocytochrome P450 BM3 and the origin of CYP102 fusion species.
Girvan HM; Waltham TN; Neeli R; Collins HF; McLean KJ; Scrutton NS; Leys D; Munro AW
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1173-7. PubMed ID: 17073779
[TBL] [Abstract][Full Text] [Related]
7. Flavocytochrome P450 BM3 substrate selectivity and electron transfer in a model cytochrome P450.
Munro AW; Noble MA; Ost TW; Green AJ; McLean KJ; Robledo L; Miles CS; Murdoch J; Chapman SK
Subcell Biochem; 2000; 35():297-315. PubMed ID: 11192726
[No Abstract] [Full Text] [Related]
8. A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme.
Joyce MG; Girvan HM; Munro AW; Leys D
J Biol Chem; 2004 May; 279(22):23287-93. PubMed ID: 15020590
[TBL] [Abstract][Full Text] [Related]
9. Flavocytochrome P-450 BM3: a paradigm for the analysis of electron transfer and its control in the P-450s.
Munro AW; Noble MA; Miles CS; Daff SN; Green AJ; Quaroni L; Rivers S; Ost TW; Reid GA; Chapman SK
Biochem Soc Trans; 1999 Feb; 27(2):190-6. PubMed ID: 10093732
[No Abstract] [Full Text] [Related]
10. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
11. Catalytically functional flavocytochrome chimeras of P450 BM3 and nitric oxide synthase.
Fuziwara S; Sagami I; Rozhkova E; Craig D; Noble MA; Munro AW; Chapman SK; Shimizu T
J Inorg Biochem; 2002 Sep; 91(4):515-26. PubMed ID: 12237219
[TBL] [Abstract][Full Text] [Related]
12. Control of electron transfer in neuronal NO synthase.
Daff S; Noble MA; Craig DH; Rivers SL; Chapman SK; Munro AW; Fujiwara S; Rozhkova E; Sagami I; Shimizu T
Biochem Soc Trans; 2001 May; 29(Pt 2):147-52. PubMed ID: 11356143
[TBL] [Abstract][Full Text] [Related]
13. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
[TBL] [Abstract][Full Text] [Related]
14. Redox control of the catalytic cycle of flavocytochrome P-450 BM3.
Daff SN; Chapman SK; Turner KL; Holt RA; Govindaraj S; Poulos TL; Munro AW
Biochemistry; 1997 Nov; 36(45):13816-23. PubMed ID: 9374858
[TBL] [Abstract][Full Text] [Related]
15. The unusual redox properties of flavocytochrome P450 BM3 flavodoxin domain.
Hanley SC; Ost TW; Daff S
Biochem Biophys Res Commun; 2004 Dec; 325(4):1418-23. PubMed ID: 15555585
[TBL] [Abstract][Full Text] [Related]
16. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
Munro AW; Daff SN; Turner KL; Chapman SK
Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
[No Abstract] [Full Text] [Related]
17. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
Fasan R; Chen MM; Crook NC; Arnold FH
Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
[No Abstract] [Full Text] [Related]
18. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
[No Abstract] [Full Text] [Related]
19. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
20. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
